Primary Site >> Liver Cancer

Gene >> TYR

Journal: J Biol Chem. 1988 Mar 5;263(7):3314-22.
Title: The oncofetal structure of human fibronectin defined by monoclonal antibody FDC-6. Unique structural requirement for the antigenic specificity provided by a glycosylhexapeptide.
Author: Matsuura, H|Takio, K|Titani, K|Greene, T|Levery, S B|Salyan, M E|Hakomori, S
PMID: 2449438
Journal: J Biol Chem. 1991 Nov 25;266(33):22661-70.
Title: Interleukin-1 represents a new modality for the activation of extracellular signal-regulated kinases/microtubule-associated protein-2 kinases.
Author: Bird, T A|Sleath, P R|deRoos, P C|Dower, S K|Virca, G D
PMID: 1658005
Journal: Gan To Kagaku Ryoho. 1992 May;19(5):612-7.
Title: [Nutritional treatment of hepatocellular carcinoma].
Author: Kurokawa, F|Yamashita, A|Okita, K
PMID: 1580635
Journal: J Nucl Med. 1995 Oct;36(10):1875-81.
Title: Technetium-99m-galactosyl-neoglycoalbumin combined with iodine-123-Tyr-(A14)-insulin visualizes human hepatocellular carcinomas.
Author: Kurtaran, A|Li, S R|Raderer, M|Leimer, M|Muller, C|Pidlich, J|Neuhold, N|Hubsch, P|Angelberger, P|Scheithauer, W
PMID: 7562058
Journal: Int J Hematol. 1995 Apr;61(3):131-7.
Title: Serum amino acid disturbance in multiple myeloma with hyperammonemia.
Author: Matsuzaki, H|Hata, H|Sonoki, T|Matsuno, F|Kuribayashi, N|Yoshida, M|Nagasaki, A|Murata, H|Fujiyama, S|Takatsuki, K
PMID: 7599324
Journal: Cancer Lett. 1996 Apr 19;102(1-2):65-71.
Title: Association of inhibition of cell growth by O-phospho-L-tyrosine with decreased tyrosine phosphorylation.
Author: Mishra, S|Hamburger, A W
PMID: 8603380
Journal: Jpn J Cancer Res. 1996 Jun;87(6):612-7.
Title: Biochemical characterization of alpha-fetoprotein and other serum proteins produced by a uterine endometrial adenocarcinoma.
Author: Koyama, Y|Taketa, K|Azuma, M|Yamamoto, R|Fujimoto, S|Nishi, S
PMID: 8766525
Journal: Recent Results Cancer Res. 1998;154:47-85.
Title: Polymorphisms of N-acetyltransferases, glutathione S-transferases, microsomal epoxide hydrolase and sulfotransferases: influence on cancer susceptibility.
Author: Hengstler, J G|Arand, M|Herrero, M E|Oesch, F
PMID: 10026993
Journal: Int J Oncol. 1999 Jun;14(6):1087-90.
Title: Serum vascular endothelial growth factor in the course of transcatheter arterial embolization of hepatocellular carcinoma.
Author: Suzuki, H|Mori, M|Kawaguchi, C|Adachi, M|Miura, S|Ishii, H
PMID: 10339662
Journal: Oncology. 2000 Nov;59(4):317-22.
Title: Interaction between haemochromatosis and transferrin receptor genes in hepatocellular carcinoma.
Author: Beckman, L E|Hagerstrand, I|Stenling, R|Van Landeghem, G F|Beckman, L
PMID: 11096344
Journal: Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):641-5.
Title: Point mutations in the murine fumarylacetoacetate hydrolase gene: Animal models for the human genetic disorder hereditary tyrosinemia type 1.
Author: Aponte, J L|Sega, G A|Hauser, L J|Dhar, M S|Withrow, C M|Carpenter, D A|Rinchik, E M|Culiat, C T|Johnson, D K
PMID: 11209059
Journal: J Nucl Med. 2001 Feb;42(2):326-36.
Title: Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics.
Author: Haubner, R|Wester, H J|Burkhart, F|Senekowitsch-Schmidtke, R|Weber, W|Goodman, S L|Kessler, H|Schwaiger, M
PMID: 11216533
Journal: Semin Nucl Med. 2002 Apr;32(2):148-55.
Title: In- and Y-DOTA-lanreotide: results and implications of the MAURITIUS trial.
Author: Virgolini, Irene|Britton, Keith|Buscombe, John|Moncayo, Roy|Paganelli, Giovanni|Riva, Pietro
PMID: 11965610
Journal: Curr Pharm Des. 2002;8(20):1781-807.
Title: Experience with indium-111 and yttrium-90-labeled somatostatin analogs.
Author: Virgolini, I|Traub, T|Novotny, C|Leimer, M|Fuger, B|Li, S R|Patri, P|Pangerl, T|Angelberger, P|Raderer, M|Burggasser, G|Andreae, F|Kurtaran, A|Dudczak, R
PMID: 12171531
Journal: Anticancer Drugs. 2003 Sep;14(8):585-8.
Title: TT-232: a somatostatin structural derivative as a potent antitumor drug candidate.
Author: Szende, B|Keri, Gy
PMID: 14501379
Journal: Hepatogastroenterology. 2003 Sep-Oct;50(53):1269-73.
Title: Plasma amino acid levels in patients with colorectal cancers and liver cirrhosis with hepatocellular carcinoma.
Author: Lee, Jenq-Chang|Chen, Ming-Jenn|Chang, Chia-Hao|Tiai, Yeh-Fung|Lin, Pin-Wen|Lai, Houng-Shi|Wang, Shan-Tair
PMID: 14571716
Journal: Mol Imaging Biol. 2003 Jan-Feb;5(1):42-8.
Title: Evaluation of positron emission tomography imaging using [68Ga]-DOTA-D Phe(1)-Tyr(3)-Octreotide in comparison to [111In]-DTPAOC SPECT. First results in patients with neuroendocrine tumors.
Author: Kowalski, Jorg|Henze, Marcus|Schuhmacher, Jochen|Macke, Helmut R|Hofmann, Michael|Haberkorn, Uwe
PMID: 14499161
Journal: Bioorg Med Chem. 2004 Sep 15;12(18):4989-94.
Title: The synthesis, distribution, and anti-hepatic cancer activity of YSL.
Author: Ding, Wenfeng|Zhang, Jiali|Yao, Zhi|Lu, Rong|Wu, Dezhu|Li, Ginfu|Shen, Zilong|Sun, Yingji|Lin, Gang|Wang, Chao|Zhao, Ming|Peng, Shiqi
PMID: 15336278
Journal:
Title: (99m)Tc-labeled [N4(0),Pro(1),Tyr(4)]bombesin
Author: Shan, Liang
PMID: 20641306
Journal: Cancer Biother Radiopharm. 2005 Apr;20(2):231-6.
Title: Differences in biodistribution between 99mTc-depreotide, 111In-DTPA-octreotide, and 177Lu-DOTA-Tyr3-octreotate in a small cell lung cancer animal model.
Author: Schmitt, Anneli|Bernhardt, Peter|Nilsson, Ola|Ahlman, Hakan|Kolby, Lars|Forssell-Aronsson, Eva
PMID: 15869461
Journal: World J Gastroenterol. 2005 Jul 7;11(25):3953-7.
Title: Somatostatin receptor subtype 2-mediated scintigraphy and localization using (99m)Tc-HYNIC-Tyr(3)-octreotide in human hepatocellular carcinoma-bearing nude mice.
Author: Li, Yong|Si, Jian-Ming|Zhang, Jun|Du, Jin|Wang, Fan|Jia, Bing
PMID: 15991301
Journal: Gastroenterology. 2005 Nov;129(5):1616-32.
Title: STAT3 NH2-terminal acetylation is activated by the hepatic acute-phase response and required for IL-6 induction of angiotensinogen.
Author: Ray, Sutapa|Boldogh, Istvan|Brasier, Allan R
PMID: 16285960
Journal: J Hepatol. 2006 Dec;45(6):825-35.
Title: Secretin receptors in the human liver: expression in biliary tract and cholangiocarcinoma, but not in hepatocytes or hepatocellular carcinoma.
Author: Korner, Meike|Hayes, Gregory M|Rehmann, Ruth|Zimmermann, Arthur|Scholz, Arne|Wiedenmann, Bertram|Miller, Laurence J|Reubi, Jean Claude
PMID: 16935383
Journal: Naunyn Schmiedebergs Arch Pharmacol. 2006 Dec;374(3):223-33.
Title: Investigation of anti-tumor mechanisms of K2154: characterization of tubulin isotypes, mitotic arrest and apoptotic machinery.
Author: Lu, Pin-Hsuan|Kung, Fan-Lu|Kuo, Sheng-Chu|Chueh, Shih-Chieh|Guh, Jih-Hwa
PMID: 17102938
Journal: Biochem Pharmacol. 2007 Jun 30;74(1):10-9.
Title: Quinolone analogue inhibits tubulin polymerization and induces apoptosis via Cdk1-involved signaling pathways.
Author: Chen, Ying-Cheng|Lu, Pin-Hsuan|Pan, Shiow-Lin|Teng, Che-Ming|Kuo, Sheng-Chu|Lin, Tsung-Ping|Ho, Yunn-Fang|Huang, Yu-Chun|Guh, Jih-Hwa
PMID: 17475221
Journal: J Nutr. 2007 Jun;137(6 Suppl 1):1556S-1560S; discussion 1573S-1575S.
Title: Animal models of tyrosinemia.
Author: Nakamura, Kimitoshi|Tanaka, Yasuhiko|Mitsubuchi, Hiroshi|Endo, Fumio
PMID: 17513424
Journal: Mol Cancer Ther. 2007 Jul;6(7):1932-41.
Title: Platelet-derived growth factor receptor-alpha: a novel therapeutic target in human hepatocellular cancer.
Author: Stock, Peggy|Monga, Dulabh|Tan, Xinping|Micsenyi, Amanda|Loizos, Nick|Monga, Satdarshan P S
PMID: 17604334
Journal: Clin Cancer Res. 2008 Oct 1;14(19):6146-53.
Title: Brivanib alaninate, a dual inhibitor of vascular endothelial growth factor receptor and fibroblast growth factor receptor tyrosine kinases, induces growth inhibition in mouse models of human hepatocellular carcinoma.
Author: Huynh, Hung|Ngo, Van Chanh|Fargnoli, Joseph|Ayers, Mark|Soo, Khee Chee|Koong, Heng Nung|Thng, Choon Hua|Ong, Hock Soo|Chung, Alexander|Chow, Pierce|Pollock, Pamela|Byron, Sara|Tran, Evelyn
PMID: 18829493
Journal: J Cell Biochem. 2008 Jul 1;104(4):1181-91.
Title: Involvement of the role of Chk1 in lithium-induced G2/M phase cell cycle arrest in hepatocellular carcinoma cells.
Author: Wang, Xiao-Ming|Li, Jiao|Feng, Xiao-Cheng|Wang, Qiong|Guan, Dong-Yin|Shen, Zong-Hou
PMID: 18247328
Journal: Cancer Lett. 2008 Dec 8;272(1):160-6.
Title: Genetic variation of Aflatoxin B1 aldehyde reductase genes (AFAR) in human tumour cells.
Author: Praml, Christian|Schulz, Wolfgang|Claas, Andreas|Mollenhauer, Jan|Poustka, Annemarie|Ackermann, Rolf|Schwab, Manfred|Henrich, Kai-Oliver
PMID: 18752886
Journal: Clin Cancer Res. 2010 May 15;16(10):2899-905.
Title: Intraindividual comparison of selective arterial versus venous 68Ga-DOTATOC PET/CT in patients with gastroenteropancreatic neuroendocrine tumors.
Author: Kratochwil, Clemens|Giesel, Frederik L|Lopez-Benitez, Ruben|Schimpfky, Nadine|Kunze, Kirsten|Eisenhut, Michael|Kauczor, Hans-Ulrich|Haberkorn, Uwe
PMID: 20460485
Journal: Hepatology. 2011 Jul;54(1):164-72.
Title: p19(ARF) /p14(ARF) controls oncogenic functions of signal transducer and activator of transcription 3 in hepatocellular carcinoma.
Author: Schneller, Doris|Machat, Georg|Sousek, Alexandra|Proell, Verena|van Zijl, Franziska|Zulehner, Gudrun|Huber, Heidemarie|Mair, Markus|Muellner, Markus K|Nijman, Sebastian M B|Eferl, Robert|Moriggl, Richard|Mikulits, Wolfgang
PMID: 21452288
Journal: Cancer Sci. 2011 Aug;102(8):1516-21.
Title: Iodine 125-labeled mesenchymal-epithelial transition factor binding peptide-click-cRGDyk heterodimer for glioma imaging.
Author: Kim, Eun-Mi|Jeong, Min-Hee|Kim, Dong Wook|Jeong, Hwan-Jeong|Lim, Seok Tae|Sohn, Myung-Hee
PMID: 21575108
Journal: Radiat Oncol. 2011 May 30;6:56.
Title: Costunolide causes mitotic arrest and enhances radiosensitivity in human hepatocellular carcinoma cells.
Author: Liu, Chia-Yuan|Chang, Hsun-Shuo|Chen, Ih-Sheng|Chen, Chih-Jen|Hsu, Ming-Ling|Fu, Shu-Ling|Chen, Yu-Jen
PMID: 21624128
Journal: Cancer Biol Ther. 2011 Sep 15;12(6):531-8.
Title: c-Met-Akt pathway-mediated enhancement of inhibitory c-Raf phosphorylation is involved in vitamin K1 and sorafenib synergy on HCC growth inhibition.
Author: Carr, Brian I|Wang, Ziqiu|Wang, Meifang|Cavallini, Aldo|D'Alessandro, Rosalba|Refolo, Maria Gratzia
PMID: 21734462
Journal: Nucl Med Commun. 2011 Nov;32(11):1095-104.
Title: Kit for preparation of multimeric receptor-specific (9)(9)mTc-radiopharmaceuticals based on gold nanoparticles.
Author: Ocampo-Garcia, Blanca|Ferro-Flores, Guillermina|Morales-Avila, Enrique|Ramirez, Flor de Maria
PMID: 21860334
Journal: J Pept Sci. 2011 Nov;17(11):763-9.
Title: Targeting of hepatocellular carcinoma with glypican-3-targeting peptide ligand.
Author: Lee, You La|Ahn, Byeong-Cheol|Lee, Yongjin|Lee, Sang-Woo|Cho, Je-Yoel|Lee, Jaetae
PMID: 21976137
Journal: Cancer Lett. 2012 Aug 1;321(1):27-35.
Title: A novel obatoclax derivative, SC-2001, induces apoptosis in hepatocellular carcinoma cells through SHP-1-dependent STAT3 inactivation.
Author: Chen, Kuen-Feng|Su, Jung-Chen|Liu, Chun-Yu|Huang, Jui-Wen|Chen, Kuei-Chiu|Chen, Wei-Lin|Tai, Wei-Tien|Shiau, Chung-Wai
PMID: 22465052
Journal: J Clin Exp Hepatol. 2012 Jun;2(2):104-11.
Title: Microsomal Epoxide Hydrolase Polymorphisms and Haplotypes as Determinants of Hepatitis B Virusand Hepatitis C Virus-related Liver Disease in Indian Population.
Author: Rahat, Beenish|Kiran, Manjula|Saxena, Roli|Chawla, Yogesh K|Sharma, Rati R|Kaur, Jyotdeep
PMID: 25755418
Journal: Nanoscale Res Lett. 2013 Jul 6;8(1):315.
Title: Peptide-biphenyl hybrid-capped AuNPs: stability and biocompatibility under cell culture conditions.
Author: Connolly, Mona|Perez, Yolanda|Mann, Enrique|Herradon, Bernardo|Fernandez-Cruz, Maria L|Navas, Jose M
PMID: 23829784
Journal: Mol Med Rep. 2013 Aug;8(2):655-61.
Title: Phosphorylation of cMet tyrosine residues in murine ascitic hepatic cancer cell lines with different lymph node metastatic potentials.
Author: Li, Ying|Huang, Xiaohua|Zhang, Qiaoshu|Ma, Keli
PMID: 23778885
Journal: Hepatology. 2013 Aug;58(2):555-63.
Title: Polymorphisms of the core, NS3, and NS5A proteins of hepatitis C virus genotype 1b associate with development of hepatocellular carcinoma.
Author: El-Shamy, Ahmed|Shindo, Michiko|Shoji, Ikuo|Deng, Lin|Okuno, Tadao|Hotta, Hak
PMID: 23281009
Journal: Cancer Lett. 2013 Jan 28;328(2):243-51.
Title: Evodiamine inhibits STAT3 signaling by inducing phosphatase shatterproof 1 in hepatocellular carcinoma cells.
Author: Yang, Jie|Cai, Xueting|Lu, Wuguang|Hu, Chunping|Xu, Xiaojun|Yu, Qiang|Cao, Peng
PMID: 23032719
Journal: J Control Release. 2013 Mar 28;166(3):203-10.
Title: Injectable hyaluronic acid-tyramine hydrogels incorporating interferon-alpha2a for liver cancer therapy.
Author: Xu, Keming|Lee, Fan|Gao, Shu Jun|Chung, Joo Eun|Yano, Hirohisa|Kurisawa, Motoichi
PMID: 23328125
Journal: Chem Biol Interact. 2014 Aug 5;219:184-94.
Title: Hellebrigenin induces cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells through inhibition of Akt.
Author: Deng, Li-Juan|Hu, Li-Ping|Peng, Qun-Long|Yang, Xiao-Lin|Bai, Liang-Liang|Yiu, Anita|Li, Yong|Tian, Hai-Yan|Ye, Wen-Cai|Zhang, Dong-Mei
PMID: 24954031
Journal: Orphanet J Rare Dis. 2014 Aug 1;9:107.
Title: Cross-sectional study of 168 patients with hepatorenal tyrosinaemia and implications for clinical practice.
Author: Mayorandan, Sebene|Meyer, Uta|Gokcay, Gulden|Segarra, Nuria Garcia|de Baulny, Helene Ogier|van Spronsen, Francjan|Zeman, Jiri|de Laet, Corinne|Spiekerkoetter, Ute|Thimm, Eva|Maiorana, Arianna|Dionisi-Vici, Carlo|Moeslinger, Dorothea|Brunner-Krainz, Michae
PMID: 25081276
Journal: J Biol Chem. 2014 Dec 5;289(49):34296-307.
Title: Development of a novel azaspirane that targets the Janus kinase-signal transducer and activator of transcription (STAT) pathway in hepatocellular carcinoma in vitro and in vivo.
Author: Mohan, Chakrabhavi Dhananjaya|Bharathkumar, Hanumantharayappa|Bulusu, Krishna C|Pandey, Vijay|Rangappa, Shobith|Fuchs, Julian E|Shanmugam, Muthu K|Dai, Xiaoyun|Li, Feng|Deivasigamani, Amudha|Hui, Kam M|Kumar, Alan Prem|Lobie, Peter E|Bender, Andreas|Basap
PMID: 25320076
Journal: EJNMMI Res. 2015 Mar 24;5:17.
Title: Neurotensin receptors in pancreatic ductal carcinomas.
Author: Korner, Meike|Waser, Beatrice|Strobel, Oliver|Buchler, Markus|Reubi, Jean Claude
PMID: 25859423
Journal: Oncogene. 2015 Oct 8;34(41):5252-63.
Title: SHP-1 is a negative regulator of epithelial-mesenchymal transition in hepatocellular carcinoma.
Author: Fan, L-C|Shiau, C-W|Tai, W-T|Hung, M-H|Chu, P-Y|Hsieh, F-S|Lin, H|Yu, H-C|Chen, K-F
PMID: 25619838
Journal: Protein Sci. 2015 Mar;24(3):328-40.
Title: Structural features of interfacial tyrosine residue in ROBO1 fibronectin domain-antibody complex: Crystallographic, thermodynamic, and molecular dynamic analyses.
Author: Nakayama, Taisuke|Mizohata, Eiichi|Yamashita, Takefumi|Nagatoishi, Satoru|Nakakido, Makoto|Iwanari, Hiroko|Mochizuki, Yasuhiro|Kado, Yuji|Yokota, Yuki|Satoh, Reiko|Tsumoto, Kouhei|Fujitani, Hideaki|Kodama, Tatsuhiko|Hamakubo, Takao|Inoue, Tsuyoshi
PMID: 25492858
Journal: Mol Imaging Biol. 2015 Jun;17(3):313-8.
Title: SUV of [68Ga]DOTATOC-PET/CT Predicts Response Probability of PRRT in Neuroendocrine Tumors.
Author: Kratochwil, C|Stefanova, M|Mavriopoulou, E|Holland-Letz, T|Dimitrakopoulou-Strauss, A|Afshar-Oromieh, A|Mier, W|Haberkorn, U|Giesel, F L
PMID: 25319765
Journal: Tumour Biol. 2016 Feb;37(2):1651-62.
Title: HIF-2alpha regulates CDCP1 to promote PKCdelta-mediated migration in hepatocellular carcinoma.
Author: Cao, Manqing|Gao, Junrong|Zhou, Hongyuan|Huang, Jiafei|You, Abin|Guo, Zhigui|Fang, Feng|Zhang, Wei|Song, Tianqiang|Zhang, Ti
PMID: 26307391
Journal: Bioorg Med Chem Lett. 2016 Feb 1;26(3):1056-1060.
Title: Adamantyl-tethered-biphenylic compounds induce apoptosis in cancer cells by targeting Bcl homologs.
Author: Anusha, Sebastian|Mohan, Chakrabhavi Dhananjaya|Ananda, Hanumappa|Baburajeev, C P|Rangappa, Shobith|Mathai, Jessin|Fuchs, Julian E|Li, Feng|Shanmugam, Muthu K|Bender, Andreas|Sethi, Gautam|Basappa|Rangappa, Kanchugarakoppal S
PMID: 26725030
Journal: Clin Nucl Med. 2016 Jun;41(6):447-53.
Title: Early Dynamic 68Ga-DOTA-D-Phe1-Tyr3-Octreotide PET/CT in Patients With Hepatic Metastases of Neuroendocrine Tumors.
Author: Sanger, Philipp Wilhelm|Freesmeyer, Martin
PMID: 26859210
Journal: Eur Rev Med Pharmacol Sci. 2016;20(4):613-9.
Title: A new cyclic RGD peptide dimer for integrin alphavbeta3 imaging.
Author: Ma, H|Hao, P|Zhang, L|Ma, C|Yan, P|Wang, R-F|Zhang, C-L
PMID: 26957261
Journal: Hum Mutat. 2016 Oct;37(10):1097-105.
Title: Silent Tyrosinemia Type I Without Elevated Tyrosine or Succinylacetone Associated with Liver Cirrhosis and Hepatocellular Carcinoma.
Author: Blackburn, Patrick R|Hickey, Raymond D|Nace, Rebecca A|Giama, Nasra H|Kraft, Daniel L|Bordner, Andrew J|Chaiteerakij, Roongruedee|McCormick, Jennifer B|Radulovic, Maja|Graham, Rondell P|Torbenson, Michael S|Tortorelli, Silvia|Scott, C Ronald|Lindor, Noral
PMID: 27397503
Journal: BMC Complement Altern Med. 2017 Jan 19;17(1):62.
Title: Sinularin induces DNA damage, G2/M phase arrest, and apoptosis in human hepatocellular carcinoma cells.
Author: Chung, Ting-Wen|Lin, Shih-Chao|Su, Jui-Hsin|Chen, Yu-Kuo|Lin, Chi-Chien|Chan, Hong-Lin
PMID: 28103869
Journal: Anticancer Agents Med Chem. 2018 Apr 17. pii: ACAMC-EPUB-89798.
Title: Synthesis, Cytotoxicity And Antioxidant Activity Of New Analogues Of Rc-121 Synthetic Derivatives Of Somatostatin.
Author: Wesselinova, Diana|Naydenova, Emilia D|Staykova, S|Goshev, I G|Vezenkov, L
PMID: 29667555
Journal: ACS Nano. 2018 Oct 23;12(10):9966-9973.
Title: Tandem Enzymatic Self-Assembly and Slow Release of Dexamethasone Enhances Its Antihepatic Fibrosis Effect.
Author: Tang, Wei|Zhao, Zhibin|Chong, Yuanyuan|Wu, Chengfan|Liu, Qingzhi|Yang, Jingbo|Zhou, Rongbin|Lian, Zhe-Xiong|Liang, Gaolin
PMID: 30285414